Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Sibyl Wray, Brooke Hayward, Fernando Dangond & Barry Singer. (2018) Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study. Expert Opinion on Drug Delivery 15:2, pages 127-135.
Read now
Read now
V Limmroth, J Reischl, B Mann, X Morosov, A Kokoschka, I Weller & T Schreiner. (2017) Autoinjector preference among patients with multiple sclerosis: results from a national survey. Patient Preference and Adherence 11, pages 1325-1334.
Read now
Read now
Alessandra Lugaresi, Francesca De Robertis, Marinella Clerico, Vincenzo Brescia Morra, Diego Centonze, Stefano Borghesan & Giorgia Teresa Maniscalco. (2016) Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study. Expert Opinion on Drug Delivery 13:7, pages 931-935.
Read now
Read now
Ivonne Weller, Anna Saake, Thomas Schreiner, Julika Vogelreuter & Nicolas Petroff. (2015) Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b. Patient Preference and Adherence 9, pages 951-959.
Read now
Read now
Antonios Bayas, Jean Christophe Ouallet, Boris Kallmann, Raymond Hupperts, Ulrich Fulda & Kurt Marhardt. (2015) Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study. Expert Opinion on Drug Delivery 12:8, pages 1239-1250.
Read now
Read now
Volker Limmroth & Kathrin Gerbershagen. (2014) Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a. Expert Opinion on Drug Delivery 11:12, pages 1969-1978.
Read now
Read now
Ali Seddighzadeh, Serena Hung, Krzysztof Selmaj, Yue Cui, Shifang Liu, Bjoern Sperling & Peter A Calabresi. (2014) Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study. Expert Opinion on Drug Delivery 11:11, pages 1713-1720.
Read now
Read now
Michael Schiff, Jonathan Jaffe, Bruce Freundlich & Patrick Madsen. (2014) New autoinjector technology for the delivery of subcutaneous methotrexate in the treatment of rheumatoid arthritis. Expert Review of Medical Devices 11:5, pages 447-455.
Read now
Read now
Ad A Kaptein. (2013) Transjecting growth hormone: continuous nightmare or controlled nuisance? Evaluation of a new needle-free device. Patient Preference and Adherence 7, pages 703-708.
Read now
Read now
Alessandra Lugaresi. (2013)
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence
. Expert Opinion on Drug Delivery 10:2, pages 273-283.
Read now
Read now
Articles from other publishers (4)
Sergio Sauri-Suárez, Sandra Quiñones-Aguilar, Arturo Contreras-Marín, Erik Omar Ramiro-Guerrero, David Zúñiga-García, Leticia Salinas-Vázquez, Leonardo Llamas-López, Carolina León-Jiménez, Adriana García-Martell, Iliana González-Hernández, Erwin Chiquete & Silvia García. (2020) Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis. PLOS ONE 15:4, pages e0230959.
Crossref
Crossref
Virginia A. Devonshire, Anthony Feinstein & Patrick Moriarty. (2016) Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study. BMC Research Notes 9:1.
Crossref
Crossref
Tjalf Ziemssen, Lauren Sylvester, Mark Rametta & Amy Perrin Ross. (2015) Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™). Neurology and Therapy 4:2, pages 125-136.
Crossref
Crossref
Glenn Matfin, Kate Van Brunt, Alan G. Zimmermann, Rebecca Threlkeld & Debra A. Ignaut. (2015) Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes. Journal of Diabetes Science and Technology 9:5, pages 1071-1079.
Crossref
Crossref